Serveur d'exploration sur l'Indium - Exploration (Accueil)

Index « Pays » - entrée « Autriche »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Australie < Autriche < Bangladesh  Facettes :

List of bibliographic references indexed by Autriche

Number of relevant bibliographic references: 119.
[0-50] [0 - 20][0 - 50][50-70]
Ident.Authors (with country if any)Title
000110 (2014) Nanoimprinted Comb Structures in a Low Bandgap Polymer: Thermal Processing and Their Application in Hybrid Solar Cells.
000128 (2014) Inverted bulk-heterojunction solar cell with cross-linked hole-blocking layer.
000380 (2013) Standardization of microfluidic cell cultures using integrated organic photodiodes and electrode arrays.
000587 (2013) Influence of morphology and polymer:nanoparticle ratio on device performance of hybrid solar cells-an approach in experiment and simulation.
000653 (2013) Highly Luminescent, Size- and Shape-Tunable Copper Indium Selenide Based Colloidal Nanocrystals.
000799 (2013) Design and evaluation of novel radiolabelled VIP derivatives for tumour targeting.
000893 (2013) Active Control of SPR by Thermoresponsive Hydrogels for Biosensor Applications.
000A02 (2012) Targeting properties of peptide-modified radiolabeled liposomal nanoparticles.
000B28 (2012) Preclinical evaluation of radiolabeled DOTA-derivatized cyclic minigastrin analogs for targeting cholecystokinin receptor expressing malignancies.
000C39 (2012) Leucocyte scintigraphy with 111In-oxine for assessment of cell trafficking after extracorporeal photopheresis.
000C53 (2012) Investigation of CuInS2 thin film formation by a low-temperature chemical deposition method.
000C63 (2012) Influence of PEGylation and RGD loading on the targeting properties of radiolabeled liposomal nanoparticles.
000D74 (2012) From highly monodisperse indium and indium tin colloidal nanocrystals to self-assembled indium tin oxide nanoelectrodes.
001053 (2011) Unit cell structure of crystal polytypes in InAs and InSb nanowires.
001092 (2011) The beam divergence of an indium LMIS at a distance of 50 μm as determined by plasma diagnostic measurements.
001165 (2011) Reprint of: High current liquid metal ion source using porous tungsten multiemitters.
001314 (2011) Investigation of the formation of CuInS2 nanoparticles by the oleylamine route: comparison of microwave-assisted and conventional syntheses.
001390 (2011) High-throughput flow injection analysis of labeled peptides in cellular samples - ICP-MS analysis versus fluorescence based detection.
001788 (2010) Radiolabeling of lipid-based nanoparticles for diagnostics and therapeutic applications: a comparison using different radiometals.
001966 (2010) High current liquid metal ion source using porous tungsten multiemitters.
001C74 (2009) SPECT/CT fusion imaging in radionuclide cisternography for localization of liquor leakage sites.
001D94 (2009) Liquid-metal-ion source development for space propulsion at ARC.
002521 (2007) Targeted therapy in nuclear medicine--current status and future prospects.
002530 (2007) Synthesis of a deoxy analogue of ADP L-glycero-D-manno-heptose.
002586 (2007) Preparation and characterization of dense films of poly(amidoamine) dendrimers on indium tin oxide.
002677 (2007) Indium ion emission from nanotube fibres.
002782 (2007) Dense passivating poly(ethylene glycol) films on indium tin oxide substrates.
002967 (2006) NaIn(CrO4)2.2H2O, the first indium(III) member of the kröhnkite family.
002A87 (2006) Comparison of 111In-DOTA-DPhe1-Tyr3-octreotide and 111In-DOTA-lanreotide scintigraphy and dosimetry in patients with neuroendocrine tumours.
002B56 (2005) Value of 111In-DOTA-lanreotide and 111In-DOTA-DPhe1-Tyr3-octreotide in differentiated thyroid cancer: results of in vitro binding studies and in vivo comparison with 18F-FDG PET.
002C10 (2005) Somatostatin receptor scintigraphy with 111In-DOTA-lanreotide and 111In-DOTA-Tyr3-octreotide in patients with stage IV melanoma: in-vitro and in-vivo results.
002C74 (2005) Octahedral-tetrahedral framework structures of InAsO4.H2O and PbIn(AsO4)(AsO3OH).
003012 (2004) Labelling of EDTMP (Multibone) with [111In], [99mTc] and [188Re] using different carriers for "cross complexation".
003053 (2004) Imaging of advanced neuroendocrine tumors with (18)F-FDOPA PET.
003156 (2003) [Octreotide scintigraphy for the diagnosis of active Graves' ophthalmopathy].
003238 (2003) Prognostic value of FDG-PET in malignant lymphoma.
003263 (2003) Near-infrared fluorescence imaging of lymph nodes using a new enzyme sensing activatable macromolecular optical probe.
003337 (2003) Expression of somatostatin receptors in uveal melanomas.
003407 (2003) 99mTc-Demotate 1: first data in tumour patients-results of a pilot/phase I study.
003413 (2003) 111In-DOTA- dPhe1-Tyr3-octreotide, 111In-DOTA-lanreotide and 67Ga citrate scintigraphy for visualisation of extranodal marginal zone B-cell lymphoma of the MALT type: a comparative study.
003540 (2002) In- and Y-DOTA-lanreotide: results and implications of the MAURITIUS trial.
003556 (2002) Experience with indium-111 and yttrium-90-labeled somatostatin analogs.
003610 (2002) Absence of therapeutic efficacy of the somatostatin analogue lanreotide in advanced primary hepatic cholangiocellular cancer and adenocarcinoma of the gallbladder despite in vivo somatostatin-receptor expression.
003734 (2001) New trends in peptide receptor radioligands.
003798 (2001) Effects of vasoactive intestinal peptide (VIP) and somatostatin (SST) on lipoprotein receptor expression by A431 tumor cells.
003800 (2001) Effects of chemotherapeutic agents on expression of somatostatin receptors in pancreatic tumor cells.
003826 (2001) Comparative somatostatin receptor scintigraphy using in-111-DOTA-lanreotide and in-111-DOTA-Tyr3-octreotide versus F-18-FDG-PET for evaluation of somatostatin receptor-mediated radionuclide therapy.
003840 (2001) Assessment of peripheral arterial vascular disease with radionuclide techniques.
003865 (2001) 111In-DOTA-lanreotide scintigraphy in patients with tumors of the lung.
003879 (2000) Value of peptide receptor scintigraphy using (123)I-vasoactive intestinal peptide and (111)In-DTPA-D-Phe1-octreotide in 194 carcinoid patients: Vienna University Experience, 1993 to 1998.
003959 (2000) New radiopharmaceuticals for receptor scintigraphy and radionuclide therapy.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=IndiumV2/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AffPays.i -k "Autriche" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/AffPays.i  \
                -Sk "Autriche" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=   *** parameter Area/wikiCode missing *** 
   |area=    IndiumV2
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    AffPays.i
   |clé=    Autriche
}}

Wicri

This area was generated with Dilib version V0.5.76.
Data generation: Tue May 20 07:24:43 2014. Site generation: Thu Mar 7 11:12:53 2024